NASDAQ:ESPR - Esperion Therapeutics SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$44.23 +1.05 (+2.43 %)
(As of 03/21/2019 04:00 PM ET)
Previous Close$43.18
Today's Range$42.63 - $44.77
52-Week Range$33.06 - $79.30
Volume414,029 shs
Average Volume599,070 shs
Market Capitalization$1.19 billion
P/E Ratio-5.87
Dividend YieldN/A
Beta2.17

SEC Filings

Esperion Therapeutics (NASDAQ:ESPR) SEC Filings

DateFilerForm TypeView
03/21/2019
4:01 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/21/2019
8:02 AM
Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/15/2019
6:50 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2019
3:57 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2019
3:57 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2019
3:50 PM
Esperion Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/28/2019
3:45 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2019
4:22 PM
Esperion Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G/A
View Filing
02/14/2019
3:30 PM
Esperion Therapeutics (Subject)
Pentwater Capital Management LP (Filed by)
Form SC 13G/A
View Filing
02/14/2019
10:16 AM
Esperion Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
View Filing
02/11/2019
1:17 PM
Esperion Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
View Filing
01/07/2019
4:10 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2019
6:45 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/03/2019
9:57 AM
Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
Form SC 13G/A
View Filing
12/26/2018
10:44 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/21/2018
4:07 PM
Esperion Therapeutics (Issuer)
Glickman Mark A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
12/21/2018
4:03 PM
Esperion Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
12/21/2018
4:03 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/19/2018
12:14 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/30/2018
4:18 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/30/2018
4:17 PM
Esperion Therapeutics (Issuer)
Lalwani Narendra D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/30/2018
4:15 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/05/2018
6:56 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Esperion Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/02/2018
4:00 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/01/2018
3:20 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
10/30/2018
3:35 PM
Boxer Capital, LLC (Filed by)
Esperion Therapeutics (Subject)
Form SC 13G/A
View Filing
10/30/2018
3:33 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Braslyn Ltd. (Reporting)
Esperion Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
Tuesday Thirteen Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
10/29/2018
6:45 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/18/2018
4:05 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/29/2018
3:56 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/27/2018
6:15 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/22/2018
6:18 AM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/06/2018
2:23 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/02/2018
3:31 PM
Esperion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/02/2018
6:31 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/03/2018
10:55 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/26/2018
4:06 PM
Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/25/2018
11:43 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
1:59 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/08/2018
4:08 PM
Esperion Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2018
1:34 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/29/2018
3:34 PM
Esperion Therapeutics (Issuer)
Shepard Jay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/29/2018
3:34 PM
Esperion Therapeutics (Issuer)
Shepard Jay (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
05/29/2018
3:32 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/25/2018
3:18 PM
Braunstein Scott (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
3:18 PM
Esperion Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
3:17 PM
Esperion Therapeutics (Issuer)
GOTTO ANTONIO M JR MD D PHIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
3:17 PM
Esperion Therapeutics (Issuer)
JANNEY DANIEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
3:17 PM
Esperion Therapeutics (Issuer)
MCGOVERN MARK E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
3:16 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
3:15 PM
Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
3:11 PM
Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/23/2018
7:25 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/22/2018
2:49 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/14/2018
3:06 PM
Esperion Therapeutics (Subject)
Partner Fund Management, L.P. (Filed by)
Form SC 13G
View Filing
05/11/2018
3:16 PM
Boxer Capital, LLC (Filed by)
Esperion Therapeutics (Subject)
Form SC 13G
View Filing
05/10/2018
3:22 PM
BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
Form SC 13G/A
View Filing
05/08/2018
6:41 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/02/2018
7:00 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/02/2018
6:55 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/13/2018
3:32 PM
Esperion Therapeutics (Filer)
Form DEF 14A
View Filing
03/29/2018
6:47 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/27/2018
6:46 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/07/2018
7:00 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/23/2018
3:38 PM
Berkowitz Jeffrey (Reporting)
Esperion Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
02/20/2018
3:37 PM
Esperion Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
02/20/2018
3:33 PM
Esperion Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/20/2018
7:06 AM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/14/2018
4:27 PM
Esperion Therapeutics (Subject)
Pentwater Capital Management LP (Filed by)
Form SC 13G/A
View Filing
02/14/2018
2:54 PM
BB BIOTECH AG (Filed by)
Esperion Therapeutics (Subject)
Form SC 13G/A
View Filing
02/09/2018
4:47 PM
Esperion Therapeutics (Issuer)
NEWTON ROGER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/01/2018
4:29 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/29/2018
1:42 PM
BlackRock Inc. (Filed by)
Esperion Therapeutics (Subject)
Form SC 13G/A
View Filing
01/29/2018
12:25 PM
DOMAIN PARTERS VII L P (Filed by)
Esperion Therapeutics (Subject)
Form SC 13D/A
View Filing
01/26/2018
4:24 PM
Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/22/2018
7:49 PM
Esperion Therapeutics (Issuer)
JANNEY DANIEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2018
8:28 AM
Esperion Therapeutics (Subject)
Meditor Group Ltd (Filed by)
Form SC 13G/A
View Filing
01/03/2018
5:01 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2018
5:01 PM
Esperion Therapeutics (Issuer)
Lalwani Narendra D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2018
5:00 PM
Esperion Therapeutics (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/29/2017
10:45 AM
Alta Partners VIII, L.P. (Filed by)
Esperion Therapeutics (Subject)
Form SC 13D/A
View Filing
12/20/2017
4:53 PM
Esperion Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2017
3:50 PM
Bartram Richard (Reporting)
Esperion Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
12/14/2017
3:48 PM
Esperion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/08/2017
3:42 PM
Esperion Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/08/2017
3:26 PM
DOMAIN PARTERS VII L P (Filed by)
Esperion Therapeutics (Subject)
Form SC 13D/A
View Filing
12/08/2017
3:14 PM
Esperion Therapeutics (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
This page was last updated on 3/21/2019 by MarketBeat.com Staff

Featured Article: Outstanding Shares

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel